EUDA Health Holdings Limited (NASDAQ:EUDA) Short Interest Up 1,736.6% in April

EUDA Health Holdings Limited (NASDAQ:EUDA) was the recipient of a large growth in short interest during the month of April. As of April 30th, there was short interest totaling 87,001 shares, a growth of 1,736.6% from the April 15th total of 4,737 shares. Currently, 3.5% of the company’s stock are sold short. Based on an average trading volume of 574,255 shares, the days-to-cover ratio is presently 0.2 days.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on EUDA shares. Weiss Ratings downgraded shares of EUDA Health from a “sell (d)” rating to a “sell (e+)” rating in a report on Friday. Greenridge Global cut their price objective on shares of EUDA Health from $120.00 to $55.00 and set a “buy” rating on the stock in a report on Monday, March 9th. Finally, Zacks Research raised shares of EUDA Health from a “strong sell” rating to a “hold” rating in a report on Friday, May 8th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, EUDA Health has an average rating of “Hold” and a consensus target price of $55.00.

Institutional Investors Weigh In On EUDA Health

An institutional investor recently bought a new position in EUDA Health stock. Jane Street Group LLC acquired a new stake in EUDA Health Holdings Limited (NASDAQ:EUDA) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund acquired 25,675 shares of the company’s stock, valued at approximately $59,000. Jane Street Group LLC owned 0.07% of EUDA Health as of its most recent filing with the SEC. 4.35% of the stock is currently owned by institutional investors.

EUDA Health Price Performance

Shares of NASDAQ EUDA traded up $0.03 during mid-day trading on Wednesday, reaching $14.38. 21,943 shares of the company’s stock were exchanged, compared to its average volume of 90,237. The firm has a market capitalization of $36.17 million, a price-to-earnings ratio of -5.99 and a beta of 0.56. EUDA Health has a 52 week low of $5.26 and a 52 week high of $86.00. The firm has a 50-day moving average price of $10.39 and a two-hundred day moving average price of $30.68.

EUDA Health (NASDAQ:EUDA) last released its earnings results on Tuesday, May 5th. The company reported ($0.44) EPS for the quarter, topping analysts’ consensus estimates of ($1.20) by $0.76. The business had revenue of $1.92 million for the quarter, compared to the consensus estimate of $3.90 million. As a group, sell-side analysts forecast that EUDA Health will post 1.6 EPS for the current fiscal year.

About EUDA Health

EUDA Health, Inc (NASDAQ:EUDA) is a healthcare technology company focused on the development and commercialization of digital health solutions and energy-based medical devices for women’s intimate health. The company’s platform combines non-invasive treatment devices with software-driven patient monitoring and analytics to support pelvic floor function, address stress urinary incontinence and enhance vaginal tissue health.

EUDA Health’s core product offerings utilize low-intensity radiofrequency energy delivered through proprietary handpieces to promote tissue remodeling and muscle activation.